Sorafenib downregulates the expression of HIV-1 Tat interactive protein 2 (HTATIP2) via the Janus kinase (JAK)-signal transducer and activator of transcription 3 (STAT3) signaling pathway, leading to induced EMT in HCC cells [116]. Here, STAT3 is linked to hepatocellular carcinoma.